DexCom
DXCM
#788
Rank
A$44.61 B
Marketcap
A$119.61
Share price
-1.08%
Change (1 day)
29.97%
Change (1 year)

EPS for DexCom (DXCM)

EPS in 2026 (TTM): A$3.77

According to DexCom's latest financial reports the company's current EPS (TTM) is A$3.91. In 2025 the company made an earnings per share (EPS) of A$3.24 an increase over its 2024 EPS that were of A$2.22.

EPS history for DexCom from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$3.7716.37%
2025A$3.2446.26%
2024A$2.224.26%
2023A$2.1360.23%
2022A$1.3366.82%
2021A$0.80
2019A$0.41-175.69%
2018A-$0.54144.07%
2017A-$0.22-24.36%
2016A-$0.296.85%
2015A-$0.28143.33%
2014A-$0.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.07 157.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.08 4.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$6.15 57.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
A$5.43 39.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
A$2.67-31.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
A-$1.40-135.91%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
A-$8.16-308.88%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
A$13.53 246.33%๐Ÿ‡บ๐Ÿ‡ธ USA